These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1667 related items for PubMed ID: 32863961
1. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer. Wu D, Zhu ZQ, Tang HX, Shi ZE, Kang J, Liu Q, Qi J. Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961 [Abstract] [Full Text] [Related]
2. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance. Shao M, Chang C, Liu Z, Chen K, Zhou Y, Zheng G, Huang Z, Xu H, Xu P, Lu B. Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110427. PubMed ID: 31408782 [Abstract] [Full Text] [Related]
3. pH-responsive oxygen self-sufficient smart nanoplatform for enhanced tumor chemotherapy and photodynamic therapy. Liu X, Wang X, Zang D, Chang Y, Su W, Li G, Zhang J, Yang P, Ma X, Guo Y. J Colloid Interface Sci; 2024 Dec 01; 675():1080-1090. PubMed ID: 39018635 [Abstract] [Full Text] [Related]
4. Fabricating polydopamine-coated MoSe2-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy. Chai S, Kan S, Sun R, Zhou R, Sun Y, Chen W, Yu B. Int J Nanomedicine; 2018 Dec 01; 13():7607-7621. PubMed ID: 30510420 [Abstract] [Full Text] [Related]
5. A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions. Zhou J, Li M, Lim WQ, Luo Z, Phua SZF, Huo R, Li L, Li K, Dai L, Liu J, Cai K, Zhao Y. Theranostics; 2018 Dec 01; 8(2):518-532. PubMed ID: 29290824 [Abstract] [Full Text] [Related]
6. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy. Liu J, Luo Z, Zhang J, Luo T, Zhou J, Zhao X, Cai K. Biomaterials; 2016 Mar 01; 83():51-65. PubMed ID: 26773665 [Abstract] [Full Text] [Related]
7. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide. Saroj S, Rajput SJ. Drug Dev Ind Pharm; 2018 Jul 01; 44(7):1198-1211. PubMed ID: 29412022 [Abstract] [Full Text] [Related]
8. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells. Zhang BB, Chen XJ, Fan XD, Zhu JJ, Wei YH, Zheng HS, Zheng HY, Wang BH, Piao JG, Li FZ. Acta Pharmacol Sin; 2021 May 01; 42(5):832-842. PubMed ID: 33824461 [Abstract] [Full Text] [Related]
9. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy. Wang X, Zhang M, Zhang L, Li L, Li S, Wang C, Su Z, Yuan Y, Pan W. Chemistry; 2017 May 11; 23(27):6586-6595. PubMed ID: 28218434 [Abstract] [Full Text] [Related]
10. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Martínez-Carmona M, Lozano D, Colilla M, Vallet-Regí M. Acta Biomater; 2018 Jan 11; 65():393-404. PubMed ID: 29127069 [Abstract] [Full Text] [Related]
11. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy. Saroj S, Rajput SJ. Drug Dev Ind Pharm; 2019 Apr 11; 45(4):532-547. PubMed ID: 30582382 [Abstract] [Full Text] [Related]
12. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T, Geng T, Md A, Banerjee P, Wang B. Colloids Surf B Biointerfaces; 2019 Apr 01; 176():185-193. PubMed ID: 30616109 [Abstract] [Full Text] [Related]
13. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo. Xiao X, Liu Y, Guo M, Fei W, Zheng H, Zhang R, Zhang Y, Wei Y, Zheng G, Li F. J Biomater Appl; 2016 Jul 01; 31(1):23-35. PubMed ID: 27059495 [Abstract] [Full Text] [Related]
14. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy. Gautam M, Thapa RK, Poudel BK, Gupta B, Ruttala HB, Nguyen HT, Soe ZC, Ou W, Poudel K, Choi HG, Ku SK, Yong CS, Kim JO. Acta Biomater; 2019 Apr 01; 88():448-461. PubMed ID: 30818051 [Abstract] [Full Text] [Related]
15. Increased Intracellular Reactive Oxygen Species Mediates the Anti-Cancer Effects of WZ35 via Activating Mitochondrial Apoptosis Pathway in Prostate Cancer Cells. Chen M, Zhou B, Zhong P, Rajamanickam V, Dai X, Karvannan K, Zhou H, Zhang X, Liang G. Prostate; 2017 Apr 01; 77(5):489-504. PubMed ID: 27990666 [Abstract] [Full Text] [Related]
16. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy. Lee S, Lee SA, Shinn J, Lee Y. Int J Nanomedicine; 2024 Apr 01; 19():4893-4906. PubMed ID: 38828202 [Abstract] [Full Text] [Related]
17. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery. Thiyagarajan V, Lin SX, Lee CH, Weng CF. Colloids Surf B Biointerfaces; 2016 May 01; 141():120-131. PubMed ID: 26851441 [Abstract] [Full Text] [Related]
18. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy. Ding X, Yu W, Wan Y, Yang M, Hua C, Peng N, Liu Y. Carbohydr Polym; 2020 Oct 01; 245():116493. PubMed ID: 32718608 [Abstract] [Full Text] [Related]
19. Facile synthesis by a covalent binding reaction for pH-responsive drug release of carboxylated chitosan coated hollow mesoporous silica nanoparticles. Liu Q, Wang J, Yang L, Xia X, Wang M, Chen S, Zhu R, Wang Q, Wu X, Wang S. IET Nanobiotechnol; 2018 Jun 01; 12(4):446-452. PubMed ID: 29768228 [Abstract] [Full Text] [Related]
20. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer. Zhao C, Cao W, Zheng H, Xiao Z, Hu J, Yang L, Chen M, Liang G, Zheng S, Zhao C. Int J Nanomedicine; 2019 Jun 01; 14():1597-1618. PubMed ID: 30880968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]